Jen Fuson

Phillips & Cohen partner Stephen Hasegawa explains the nature of the alleged kickbacks in the case against ResMed in a FierceHealthcare article: The company charged service fees to those who sold competitors’...

Washington, DC, Jan. 17, 2020 – US News & World Report and bestlawyers.com have named Phillips & Cohen LLP to their annual rankings of U.S. News – Best Lawyers® “Best Law Firms” for 2020,...

Phillips & Cohen Files Qui Tam Case Alleging Kickbacks ResMed Inc., a medical equipment manufacturer, has agreed to pay a total of $39.5 million to the federal government and certain states to settle...

Whistleblowers continue to deliver the federal government’s most significant wins against fraud, with “qui tam” cases responsible for most of the $3.05 billion the government recovered from fraud-related...

Phillips & Cohen partner Colette Matzzie contributes insights to a Bloomberg Law article about how pharmaceutical companies seeking patent extensions on brand-name drugs may encounter new legal challenges...

Phillips & Cohen attorney Molly Knobler praises her whistleblower client, Dr. Clark Searle, in Wisconsin Public Radio’s coverage of a $10 million payment by Agnesian Healthcare and its affiliated...

MILWAUKEE, WISCONSIN, Jan. 6, 2020 – Agnesian Healthcare and its affiliated physician group in Wisconsin have agreed to pay $10 million to the federal government and the state of Wisconsin to settle...

WASHINGTON, DC, Dec. 18, 2019 – Lawdragon magazine has named 10 Phillips & Cohen attorneys to its list of the “500 Leading Plaintiff Financial Lawyers” for 2019. Phillips & Cohen...

In an article for Forbes.com, Phillips & Cohen partner Erika Kelton argues for clarity in the SEC’s position as it considers changes to its whistleblower program: The future success of the Securities...

Kickbacks by the pharmaceutical industry come in many forms. One of the latest twists in pharma kickbacks involves patient assistance foundations conspiring with drug manufacturers to increase manufacturers’...